BioWorld

Aug. 18, 2010

View Archived Issues

Lilly's Semagacestat Out; Gamma Secretase Still In?

NewCo News: Fabrus Forges Ahead with Therapeutic Antibody Platform

Clinic Roundup

Stock Movers

Other News To Note

Appointments And Advancements

Financings Roundup

Eyeing Regenerative Medicine, Medtronic Acquires Osteotech

Medical device maker Medtronic Inc. staked a deeper claim in the regenerative biologics field by moving to acquire Osteotech Inc. for $6.50 per share, or $123 million. (BioWorld Today) Read More

Will Shire's Exit Be Chelsea's Gain in Hypotension Market?

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...